InsiderClue
Insiders · Profile

FORMELA JEAN FRANCOIS

Director at Korro Bio · Director at ImageneBio · Director at Intellia Therapeutics · and 2 more. Filing since 29 Mar 2010. CIK 0001030575

KRRO Korro Bio, Inc. Director · 11 trades IMA ImageneBio, Inc. Director · 4 trades NTLA Intellia Therapeutics, Inc. Director · 19 trades SPRO Spero Therapeutics, Inc. Director · 1 trade ORKA Oruka Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
KRRO Korro Bio, Inc.
14 Sep 2026
Director
Sold on a plan
38,490
$543.48K
22.5%
KRRO Korro Bio, Inc.
11 Sep 2026
Director
Sold on a plan
10,200
$142.70K
6.8%
KRRO Korro Bio, Inc.
26 Aug 2026
Director
Sold on a plan
300
$4.19K
0.2%
KRRO Korro Bio, Inc.
19 Aug 2026
Director
Sold on a plan
28,468
$398.55K
16.8%
KRRO Korro Bio, Inc.
11 Aug 2026
Director
Sold on a plan
2,143
$29.92K
1.4%
KRRO Korro Bio, Inc.
6 Jul 2026
Director
Sold on a plan
9,323
$130.15K
6.0%
KRRO Korro Bio, Inc.
2 Jul 2026
Director
Sold on a plan
100,700
$1.41M
39.4%
KRRO Korro Bio, Inc.
24 Jun 2026
Director
Sold on a plan
48,438
$707.49K
22.2%
KRRO Korro Bio, Inc.
23 Jun 2026
Director
Sold on a plan
119,005
$1.70M
40.3%
KRRO Korro Bio, Inc.
22 Jun 2026
Director
Sold on a plan
3,962
$55.27K
2.0%
KRRO Korro Bio, Inc.
28 May 2026
Director
Sold on a plan
2,860
$39.90K
1.4%
IMA ImageneBio, Inc.
14 Dec 2021
Director
Sold, plan not stated
5,959
$83.43K
0.5%
IMA ImageneBio, Inc.
13 Dec 2021
Director
Sold, plan not stated
8,330
$121.95K
0.7%
IMA ImageneBio, Inc.
10 Dec 2021
Director
Sold, plan not stated
11,989
$180.19K
0.9%
NTLA Intellia Therapeutics, Inc.
28 Jun 2021
Director
Sold, plan not stated
553,376
$73.45M
98.2%
NTLA Intellia Therapeutics, Inc.
14 Jun 2021
Director
Sold, plan not stated
170,126
$14.86M
23.2%
NTLA Intellia Therapeutics, Inc.
14 Jun 2021
Director
Sold, plan not stated
653
$58.28K
0.1%
NTLA Intellia Therapeutics, Inc.
11 Jun 2021
Director
Sold, plan not stated
30,946
$2.64M
4.0%
NTLA Intellia Therapeutics, Inc.
29 Apr 2021
Director
Sold, plan not stated
4,513
$385.55K
0.6%
NTLA Intellia Therapeutics, Inc.
28 Apr 2021
Director
Sold, plan not stated
131,926
$11.29M
14.6%
NTLA Intellia Therapeutics, Inc.
27 Apr 2021
Director
Sold, plan not stated
210,230
$18.13M
18.9%
NTLA Intellia Therapeutics, Inc.
26 Apr 2021
Director
Sold, plan not stated
806
$68.45K
0.1%
NTLA Intellia Therapeutics, Inc.
5 Apr 2021
Director
Sold, plan not stated
800
$67.98K
0.1%
IMA ImageneBio, Inc.
30 Mar 2021
Director
Bought
125,000
$2.00M
16.7%
NTLA Intellia Therapeutics, Inc.
26 Feb 2021
Director
Sold, plan not stated
501,945
$30.26M
31.1%
NTLA Intellia Therapeutics, Inc.
16 Jul 2018
Director
Sold, plan not stated
6,686
$208.40K
100%
NTLA Intellia Therapeutics, Inc.
19 Jun 2018
Director
Sold, plan not stated
6,686
$186.91K
100%
NTLA Intellia Therapeutics, Inc.
16 May 2018
Director
Sold, plan not stated
6,686
$167.39K
100%
NTLA Intellia Therapeutics, Inc.
20 Mar 2018
Director
Sold, plan not stated
39,245
$936.74K
100%
SPRO Spero Therapeutics, Inc.
6 Nov 2017
Director
Bought
428,571
$6.00M
21.6%
NTLA Intellia Therapeutics, Inc.
11 Jul 2017
Director
Sold, plan not stated
80,000
$1.29M
2.2%
NTLA Intellia Therapeutics, Inc.
10 Jul 2017
Director
Sold, plan not stated
40,000
$646.89K
1.1%
NTLA Intellia Therapeutics, Inc.
7 Jul 2017
Director
Sold, plan not stated
30,000
$502.99K
0.8%
NTLA Intellia Therapeutics, Inc.
10 Mar 2017
Director
Sold, plan not stated
5,504
$77.41K
100%
NTLA Intellia Therapeutics, Inc.
9 Mar 2017
Director
Sold, plan not stated
15,628
$216.43K
74.0%
ORKA Oruka Therapeutics, Inc.
29 Mar 2010
Director
Sold, plan not stated
140,000
$1.06M
9.5%
36 decisions on file.